Effects of periodontitis on aortic insulin resistance in an obese rat model

Laboratory Investigation

Volumn 90, Issue 3, 2010, Pages 348-359

  Ekuni, Daisuke ^a   Tomofuji, Takaaki ^a   Irie, Koichiro ^a   Kasuyama, Kenta ^a   Umakoshi, Michihiro ^a   Azuma, Tetsuji ^a   Tamaki, Naofumi ^a   Sanbe, Toshihiro ^a   Endo, Yasumasa ^a   Yamamoto, Tatsuo ^b   Nishida, Takashi ^a   Morita, Manabu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

Animal models; Atherosclerosis; Insulin resistance; Obesity; Periodontal disease

Indexed keywords

3 NITROTYROSINE; C REACTIVE PROTEIN; ENDOTHELIN 1; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DESCENDING AORTA; ENZYME PHOSPHORYLATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; LIPID STORAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZUCKER RAT;

EID: 77649174064     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.141     Document Type: Article

References (70)

1. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003;108:1546-1551.
2. Hayden JM, Reaven PD. Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors. Curr Opin Lipidol 2000;11:519-528.
3. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115:37S-41S.
4. Hanley AJ, Williams K, Stern MP, et al. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002;25: 1177-1184.
5. Haffner SM, D'Agostino Jr R, Mykkänen L, et al. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1999;22:562-568.
6. Sinaiko AR, Steinberger J, Moran A, et al. Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence. Circulation 2005;111:1985-1991.
7. Prior JO, Quinones MJ, Hernandez-Pampaloni M, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation 2005;111: 2291-2298.
8. Tousoulis D, Tsarpalis K, Cokkinos D, et al. Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications. Diabetes Obes Metab 2008;10:834-842.
9. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904.
10. Zeng G, Nystrom FH, Ravichandran LV, et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000;101:1539-1545.
11. Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 2003;111:1373-1380.
12. Duncan ER, Crossey PA, Walker S, et al. Effect of endothelium-specific insulin resistance on endothelial function in vivo. Diabetes 2008;57:3307-3314.
13. Page RC, Engel LD, Narayanan AS, et al. Chronic inflammatory gingival and periodontal disease. JAMA 1978;11:545-550.
14. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-1820.
15. Cueto A, Mesa F, Bravo M, et al. Periodontitis as risk factor for acute myocardial infarction. A case control study of Spanish adults. J Periodontal Res 2005;40:36-42.
16. Janket SJ, Baird AE, Chuang SK, et al. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:559-569.
17. Söder PO, Söder B, Nowak J, et al. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke 2005;36:1195-1200.
18. Spahr A, Klein E, Khuseyinova N, et al. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med 2006;166:554-559.
19. Ekuni D, Tomofuji T, Sanbe T, et al. Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J Periodontal Res 2009;44:434-442.
20. Janssen U, Phillips AO, Floege J. Rodent models of nephropathy associated with type II diabetes. J Nephrol 1999;12:159-172.
21. Kearney MT, Duncan ER, Kahn M, et al. Insulin resistance and endothelial cell dysfunction: studies in mammalian models. Exp Physiol 2008;93:158-163.
22. Irie K, Tomofuji T, Tamaki N, et al. Effects of ethanol consumption on periodontal inflammation in rats. J Dent Res 2008;87:456-460.
23. Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, et al. Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiol Endocrinol Metab 2003;285:E216-E223.
24. Ekuni D, Yamamoto T, Yamanaka R, et al. Proteases augment the effects of lipopolysaccharide in rat gingiva. J Periodontal Res 2003;38:591-596.
25. Kawata K, Eguchi T, Kubota S, et al. Possible role of LRP1, a CCN2 receptor, in chondrocytes. Biochem Biophys Res Commun 2006;345:552-559.
26. Peinnequin A, Mouret C, Birot O, et al. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol 2004;5:3.
27. Simler N, Grosfeld A, Peinnequin A, et al. Leptin receptor-deficient obese Zucker rats reduce their food intake in response to hypobaric hypoxia. Am J Physiol Endocrinol Metab 2006;290:E591-E597.
28. Uruno A, Sugawara A, Kanatsuka H, et al. Upregulation of nitric oxide production in vascular endothelial cells by all-trans retinoic acid through the phosphoinositide 3-kinase/Akt pathway. Circulation 2005;112:727-736.
29. Berti R, Williams AJ, Moffett JR, et al. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab 2002;22: 1068-1079.
30. Fukuda G, Khan ZA, Barbin YP, et al. Endothelin-mediated remodeling in aortas of diabetic rats. Diabetes Metab Res Rev 2005;21: 367-375.
31. Ekuni D, Tomofuji T, Sanbe T, et al. Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch Oral Biol 2009;54:495-502.
32. Tang J, Kozaki K, Farr AG, et al. The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE-/-mice. Am J Pathol 2005;167:901-912.
33. Escribese MM, Conde E, Mart́in A, et al. Therapeutic effect of all-trans-retinoic acid (at-RA) on an autoimmune nephritis experimental model: role of the VLA-4 integrin. BMC Nephrol 2007;8:3.
34. Kokk K, Verajankorva E, Wu XK, et al. Expression of insulin signaling transmitters and glucose transporters at the protein level in the rat testis. Ann N Y Acad Sci 2007;1095:262-273.
35. Cai F, Helke CJ. Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats. Brain Res Mol Brain Res 2003;110:234-244.
36. Wang R, Zhang QG, Han D, et al. Inhibition of MLK3-MKK4/7-JNK1/2 pathway by Akt1 in exogenous estrogen-induced neuroprotection against transient global cerebral ischemia by a non-genomic mechanism in male rats. J Neurochem 2006;99:1543-1554.
37. Tomofuji T, Ekuni D, Yamanaka R, et al. Chronic administration of lipopolysaccharide and proteases induces periodontal inflammation and hepatic steatosis in rats. J Periodontol 2007;78:1999-2006.
38. Ackermans MT, Klieverik LP, Endert E, et al. Plasma insulin concentrations during a hyperinsulinaemic clamp: what do we measure? Ann Clin Biochem 2008;45:429-430.
39. Chiba T, Komatsu T, Nakayama M, et al. Similar metabolic responses to calorie restriction in lean and obese Zucker rats. Mol Cell Endocrinol 2009;309:17-25.
40. Liu R, Bal HS, Desta T, et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 2006;85:510-514.
41. Bjørbaek C, Elmquist JK, Frantz JD, et al. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell 1998;1:619-625.
42. Wang ZW, Pan WT, Lee Y, et al. The role of leptin resistance in the lipid abnormalities of aging. FASEB J 2001;15:108-114.
43. Shi H, Tzameli I, Bjørbaek C, et al. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem 2004;279:34733-34740.
44. Steppan CM, Wang J, Whiteman EL, et al. Activation of SOCS-3 by resistin. Mol Cell Biol 2005;25:1569-1575.
45. Emanuelli B, Peraldi P, Filloux C, et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem 2001;276:47944-47949.
46. Montagnani M, Golovchenko I, Kim I, et al. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002;277:1794-1799.
47. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006;113:1888-1904.
48. Muñoz MC, Argentino DP, Dominici FP, et al. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats. J Hypertens 2006;24:1607-1617.
49. Di Paola R, Marzocco S, Mazzon E, et al. Effect of aminoguanidine in ligature-induced periodontitis in rats. J Dent Res 2004;83:343-348.
50. Tomofuji T, Ekuni D, Sanbe T, et al. Effects of vitamin C intake on gingival oxidative stress in rat periodontitis. Free Radic Biol Med 2009;46:163-168.
51. Tomofuji T, Ekuni D, Irie K, et al. Preventive effects of a cocoa-enriched diet on gingival oxidative stress in experimental periodontitis. J Periodontol 2009;80:1799-1808.
52. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
53. Ridker PM, Cushman M, Stampfer MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-428.
54. Noack B, Genco RJ, Trevisan M, et al. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227.
55. Craig RG, Yip JK, So MK, et al. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003;74: 1007-1016.
56. Yudkin JS, Stehouwer CD, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978.
57. Iwamoto Y, Nishimura F, Nakagawa M, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-778.
58. Iwamoto Y, Nishimura F, Soga Y, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74:1231-1236.
59. Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance-lessons from obesity. J Dent Res 2001;80:1690-1694.
60. Barath P, Fishbein MC, Cao J, et al. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990;65:297-302.
61. Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-921.
62. Emanuelli B, Peraldi P, Filloux C, et al. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 2000;275: 15985-15991.
63. Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol 2004;24:5434-5446.
64. Rui L, Yuan M, Frantz D, et al. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002;277:42394-42398.
65. Watanabe K, Petro BJ, Shlimon AE, et al. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats. J Periodontol 2008;79:1208-1216.
66. Shi H, Cave B, Inouye K, et al. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 2006;55:699-707.
67. Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension 1992;19:I110-I115.
68. Shimamura T, Amorosa LF, Wilson AC, et al. Atherosclerosis and glomerulosclerosis in WHHL rabbits and obese Zucker rats. Jpn J Exp Med 1990;60:105-109.
69. Kavurma MM, Bennett MR. Expression, regulation and function of trail in atherosclerosis. Biochem Pharmacol 2008;75:1441-1450.
70. Vaskonen T, Mervaala E, Krogerus L, et al. Supplementation of plant sterols and minerals benefits obese Zucker rats fed an atherogenic diet. J Nutr 2002;132:231-237. (Pubitemid 34135600)